An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD.
We recently found increased adrenal cortisol responses to adrenocorticotropic hormone (ACTH)1-24 and increased pituitary ACTH and adrenal cortisol responses to corticotropin-releasing factor in premenopausal women with chronic post-traumatic stress disorder (PTSD) compared to healthy nontraumatized subjects. This pattern of hypothalamic-pituitary-adrenal axis (HPA) hyper-reactivity has been previously seen in healthy individuals treated with the antiglucocorticoid mifepristone. We therefore investigated whether endogenous plasma levels of antiglucocorticoids such as dehydroepiandrosteroine (DHEA) and progesterone were increased in premenopausal women with PTSD at baseline or in response to adrenal activation by ACTH1-24. The study revealed that DHEA responses to 250 microg ACTH1-24 were increased in 13 PTSD subjects compared to 13 healthy nontraumatized subjects, while DHEA levels were generally increased in the PTSD subjects compared to seven healthy traumatized subjects. Cortisol responses to ACTH1-24 were also higher in the women with PTSD, while progesterone levels and responses were not different among the three groups. In addition, among the PTSD subjects, the peak change in DHEA in response to ACTH1-24 was negatively correlated with the total Clinician Administered PTSD Scale score, while the peak DHEA to cortisol ratio was inversely associated with negative mood symptoms measured by the Profile of Mood States scale. This work suggests that an increased capacity for DHEA release in response to extreme adrenal activation may influence the pattern of HPA axis adaptation to extreme stress, as well as mitigate the severity of PTSD and negative mood symptoms in premenopausal women with PTSD.
Rasmusson
Ann M
AM
Department of Psychiatry, Yale University School of Medicine & VA National Center for PTSD, Clinical Neuroscience Division, VA Boston Healthcare System, West Haven, CT 06516, USA. ann.rasmusson@yale.edu
Vasek
Jitka
J
Lipschitz
Deborah S
DS
Vojvoda
Dolores
D
Mustone
Mary Ellen
ME
Shi
Quihu
Q
Gudmundsen
Gretchen
G
Morgan
Charles A
CA
Wolfe
Jessica
J
Charney
Dennis S
DS
D000311:Adrenal Glands / Q000378:metabolism*; D000328:Adult; D000375:Aging / Q000502:physiology; D001519:Behavior / Q000502:physiology; D003366:Cosyntropin; D003687:Dehydroepiandrosterone / Q000097:blood*; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008597:Menstrual Cycle / Q000502:physiology; D019964:Mood Disorders / Q000378:metabolism* / Q000523:psychology*; D011374:Progesterone / Q000097:blood; D011569:Psychiatric Status Rating Scales; D013313:Stress Disorders, Post-Traumatic / Q000378:metabolism* / Q000523:psychology*
D004967:Estrogens; D003366:Cosyntropin; D003687:Dehydroepiandrosterone; D011374:Progesterone; D019314:Dehydroepiandrosterone Sulfate; D006854:Hydrocortisone